Atherosclerotic heart disease
is defined as an occlusion or blockage due to a buildup of plaque in the arteries which supply blood to the heart muscle.
The first six months after a heart attack is a particularly high-risk period for SCD in patients who have atherosclerotic heart disease
Since nanobacteria are physically present in the diseased atherosclerotic tissues and are statistically correlated with heart disease calcification levels, it is also reasonable to assume that long term nanobacteria infection is involved in the development of the calcification in atherosclerotic heart disease
Research Breakthrough Will Aid in Developing Therapies to Prevent and Reverse Atherosclerotic Heart Disease
The aim of the Center is to provide better care for patients with atherosclerotic heart disease
through the application of modern genetic approaches.
Coronary heart disease, also called coronary artery disease or atherosclerotic heart disease
, is the result of the accumulation of plaque build up on the walls of the arteries.
Published research on Nanobacteria has shown it to be involved in the development of atherosclerotic heart disease
, kidney stones, gallstones and other diseases related to pathological calcification.
A particularly promising area for biolitec for use of these new formulations is in the treatment of vulnerable plaque in atherosclerotic heart disease
, the underlying cause of heart attacks which each year kill over 700,000 people in the United States.